CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 30,500
-1,100 (-3.48%)
At close: Apr 9, 2026
CellBion Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -7,574 | -7,266 | -3,633 | -6,382 | -4,778 |
Depreciation & Amortization | 778.64 | 625.05 | 603.86 | 763.82 | 978.71 |
Other Amortization | - | - | 13.83 | 3.92 | 4.65 |
Loss (Gain) From Sale of Assets | 0.03 | -1.29 | -9.89 | - | 0 |
Stock-Based Compensation | 525.41 | 404.45 | 125.83 | 538.75 | 247.57 |
Other Operating Activities | -95.58 | -986.9 | -4,067 | -1,208 | 31.28 |
Change in Accounts Receivable | 50.62 | 124.36 | -174.37 | -184.06 | 93.69 |
Change in Inventory | 39.29 | -58.3 | 94.18 | -358.11 | -200.93 |
Change in Accounts Payable | 136.91 | 35.05 | -195.57 | 172.23 | 80.65 |
Change in Unearned Revenue | 595.62 | 1,658 | 2,974 | 2,677 | 555.39 |
Change in Other Net Operating Assets | -2.72 | 688.82 | 331.89 | -664.09 | -503.94 |
Operating Cash Flow | -5,545 | -4,777 | -3,936 | -4,640 | -3,491 |
Capital Expenditures | -1,472 | -126.99 | -304.08 | -433.86 | -81.43 |
Sale of Property, Plant & Equipment | - | - | 55.08 | - | - |
Sale (Purchase) of Intangibles | -207.19 | -18.16 | -113.91 | -91.58 | -117.24 |
Investment in Securities | 8,307 | -23,750 | -2,323 | 5,763 | -6,790 |
Other Investing Activities | -124.19 | 64 | 150.39 | 93.25 | 24.5 |
Investing Cash Flow | 6,504 | -23,831 | -2,536 | 5,331 | -6,964 |
Long-Term Debt Issued | - | 1,200 | - | - | - |
Total Debt Issued | - | 1,200 | - | - | - |
Short-Term Debt Repaid | - | - | -2,050 | -31 | - |
Long-Term Debt Repaid | -518.46 | -456.37 | -437.86 | -440.77 | -362.72 |
Total Debt Repaid | -518.46 | -456.37 | -2,488 | -471.77 | -362.72 |
Net Debt Issued (Repaid) | -518.46 | 743.63 | -2,488 | -471.77 | -362.72 |
Issuance of Common Stock | 292.37 | 28,121 | 8,308 | 19.32 | 10,536 |
Other Financing Activities | 23.86 | 84.26 | 181.81 | 174.9 | 32.56 |
Financing Cash Flow | -202.23 | 28,949 | 6,002 | -277.54 | 10,206 |
Foreign Exchange Rate Adjustments | 0.02 | -0.93 | - | - | - |
Net Cash Flow | 756.06 | 339.55 | -470.12 | 413.33 | -249.2 |
Free Cash Flow | -7,018 | -4,904 | -4,240 | -5,074 | -3,572 |
Free Cash Flow Margin | -360.79% | -214.16% | -288.18% | -287.84% | -389.58% |
Free Cash Flow Per Share | - | -483.08 | -427.43 | -522.88 | -406.23 |
Cash Interest Paid | 29.09 | 24.68 | 13.63 | 12.42 | 9.88 |
Cash Income Tax Paid | 96.45 | 17.48 | -7.93 | 12.53 | 3.6 |
Levered Free Cash Flow | -5,669 | -3,507 | -5,053 | -2,676 | -2,369 |
Unlevered Free Cash Flow | -5,584 | -3,425 | -4,965 | -2,456 | -2,196 |
Change in Working Capital | 819.72 | 2,448 | 3,030 | 1,643 | 24.86 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.